<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_Em4Dcna">Machine learning score to predict in-hospital outcomes in patients hospitalized in cardiac intensive care unit</title>
				<funder>
					<orgName type="full">AstraZeneca</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100004325</idno>
				</funder>
				<funder>
					<orgName type="full">Boehringer Ingelheim</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100008349</idno>
				</funder>
				<funder>
					<orgName type="full">Bristol-Myers Squibb/Pfizer</orgName>
				</funder>
				<funder>
					<orgName type="full">General Electric</orgName>
					<orgName type="abbreviated">GE</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100004313</idno>
				</funder>
				<funder>
					<orgName type="full">Bayer</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100004326</idno>
				</funder>
				<funder>
					<orgName type="full">Sanofi</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100004339</idno>
				</funder>
				<funder>
					<orgName type="full">Biosensors</orgName>
				</funder>
				<funder>
					<orgName type="full">Bristol-Myers Squibb/ Pfizer</orgName>
				</funder>
				<funder>
					<orgName type="full">Daiichi-Sankyo</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100002973</idno>
				</funder>
				<funder>
					<orgName type="full">Fondation Coeur et Recherche</orgName>
				</funder>
				<funder>
					<orgName type="full">French Society of Cardiology&apos; (Paris, France)</orgName>
				</funder>
				<funder>
					<orgName type="full">Servier</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100011725</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">† The ADDICT-ICCU Investigators. The list of the ADDICT-ICCU Investigators is available in the supplementary material. © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Downloaded from https://academic.oup.com/ehjdh/article/6/2/218/7929557 by guest on 17 July 2025 . . . . . . . . . . .</p>
				</availability>
				<date type="published" when="2024-12-20">20 December 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Orianne</forename><surname>Weizman</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Cardiology , APHP-Hopital Ambroise Paré , 92100 Boulogne Billancourt , France ;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">APHP-Hopital Ambroise Paré</orgName>
								<address>
									<postCode>92100</postCode>
									<settlement>Boulogne Billancourt</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Université Paris-Cité , PARCC , INSERM , 75015 Paris , France;</note>
								<orgName type="institution" key="instit1">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit2">PARCC</orgName>
								<orgName type="institution" key="instit3">INSERM</orgName>
								<address>
									<postCode>75015</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kenza</forename><surname>Hamzi</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Henry</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guillaume</forename><surname>Schurtz</surname></persName>
							<affiliation key="aff4">
								<note type="raw_affiliation"><label>5</label> Department of Cardiology , University Hospital of Lille , Lille , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">University Hospital of Lille</orgName>
								<address>
									<settlement>Lille</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marie</forename><surname>Hauguel-Moreau</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Cardiology , APHP-Hopital Ambroise Paré , 92100 Boulogne Billancourt , France ;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">APHP-Hopital Ambroise Paré</orgName>
								<address>
									<postCode>92100</postCode>
									<settlement>Boulogne Billancourt</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Antonin</forename><surname>Trimaille</surname></persName>
							<affiliation key="aff5">
								<note type="raw_affiliation"><label>6</label> Department of Cardiology , Nouvel Hôpital Civil , Strasbourg University Hospital , 67000 Strasbourg , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Nouvel Hôpital Civil</orgName>
								<orgName type="institution" key="instit2">Strasbourg University Hospital</orgName>
								<address>
									<postCode>67000</postCode>
									<settlement>Strasbourg</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Bedossa</surname></persName>
							<affiliation key="aff6">
								<note type="raw_affiliation"><label>7</label> Department of Cardiology , CHU Rennes , 35000 Rennes , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">CHU Rennes</orgName>
								<address>
									<postCode>35000</postCode>
									<settlement>Rennes</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jean</forename><forename type="middle">Claude</forename><surname>Dib</surname></persName>
							<affiliation key="aff7">
								<note type="raw_affiliation"><label>8</label> Department of Cardiology , Clinique Ambroise Paré , Neuilly-sur-Seine , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Clinique Ambroise Paré</orgName>
								<address>
									<settlement>Neuilly-sur-Seine</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sabir</forename><surname>Attou</surname></persName>
							<affiliation key="aff8">
								<note type="raw_affiliation"><label>9</label> Department of Cardiology , Caen University Hospital , Caen , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Caen University Hospital</orgName>
								<address>
									<settlement>Caen</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tanissia</forename><surname>Boukertouta</surname></persName>
							<affiliation key="aff9">
								<note type="raw_affiliation"><label>10</label> Department of Cardiology , Hôpital Avicenne , Assistance Publique-Hôpitaux de Paris , Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Hôpital Avicenne</orgName>
								<orgName type="institution" key="instit2">Assistance Publique-Hôpitaux de Paris</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Franck</forename><surname>Boccara</surname></persName>
							<affiliation key="aff10">
								<note type="raw_affiliation"><label>11</label> Department of Cardiology , Saint-Antoine Hospital , APHP , Sorbonne University , Paris , France;</note>
								<orgName type="department" key="dep1">Department of Cardiology</orgName>
								<orgName type="department" key="dep2">Saint-Antoine Hospital</orgName>
								<orgName type="institution" key="instit1">APHP</orgName>
								<orgName type="institution" key="instit2">Sorbonne University</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thibaut</forename><surname>Pommier</surname></persName>
							<affiliation key="aff11">
								<note type="raw_affiliation"><label>12</label> Department of Cardiology , University Hospital , Dijon , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Dijon</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Pascal</forename><surname>Lim</surname></persName>
							<affiliation key="aff12">
								<note type="raw_affiliation"><label>13</label> Intensive Cardiac Care Department , University Hospital Henri Mondor , 94000 Créteil , France;</note>
								<orgName type="department">Intensive Cardiac Care Department</orgName>
								<orgName type="institution">University Hospital Henri Mondor</orgName>
								<address>
									<postCode>94000</postCode>
									<settlement>Créteil</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Bochaton</surname></persName>
							<affiliation key="aff13">
								<note type="raw_affiliation"><label>14</label> Intensive Cardiological Care Division , Louis Pradel Hospital , Hospices Civils de Lyon , Bron , France;</note>
								<orgName type="department">Intensive Cardiological Care Division</orgName>
								<orgName type="institution" key="instit1">Louis Pradel Hospital</orgName>
								<orgName type="institution" key="instit2">Hospices Civils de Lyon</orgName>
								<address>
									<settlement>Bron</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Damien</forename><surname>Millischer</surname></persName>
							<affiliation key="aff14">
								<note type="raw_affiliation"><label>15</label> Cardiology Department , Montfermeil Hospital , 93370 Montfermeil , France;</note>
								<orgName type="department">Cardiology Department</orgName>
								<orgName type="institution">Montfermeil Hospital</orgName>
								<address>
									<postCode>93370</postCode>
									<settlement>Montfermeil</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Benoit</forename><surname>Merat</surname></persName>
							<affiliation key="aff15">
								<note type="raw_affiliation"><label>16</label> Cardiology and Aeronautical Medicine Department , Hôpital d&apos;Instruction des Armées Percy , 101 Avenue Henri Barbusse , 92140 Clamart , France;</note>
								<orgName type="department">Cardiology and Aeronautical Medicine Department</orgName>
								<orgName type="institution">Hôpital d&apos;Instruction des Armées Percy</orgName>
								<address>
									<addrLine>101 Avenue Henri Barbusse</addrLine>
									<postCode>92140</postCode>
									<settlement>Clamart</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fabien</forename><surname>Picard</surname></persName>
							<affiliation key="aff16">
								<note type="raw_affiliation"><label>17</label> Cardiology Department , Hôpital Cochin , Paris , France;</note>
								<orgName type="department">Cardiology Department</orgName>
								<orgName type="institution">Hôpital Cochin</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nissim</forename><surname>Grinberg</surname></persName>
							<affiliation key="aff17">
								<note type="raw_affiliation"><label>18</label> Cardiology Department , Hôpital Mignot , Versailles , France;</note>
								<orgName type="department">Cardiology Department</orgName>
								<orgName type="institution">Hôpital Mignot</orgName>
								<address>
									<settlement>Versailles</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Sulman</surname></persName>
							<affiliation key="aff18">
								<note type="raw_affiliation"><label>19</label> Department of Cardiology , Hôpital Bichat , Assistance Publique- Hôpitaux de Paris , Université de Paris , Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">Hôpital Bichat</orgName>
								<orgName type="institution" key="instit2">Assistance Publique- Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit3">Université de Paris</orgName>
								<address>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bastien</forename><surname>Pasdeloup</surname></persName>
							<affiliation key="aff19">
								<note type="raw_affiliation"><label>20</label> IMT Atlantique , Lab-STICC , UMR CNRS 6285 , 29238 Brest , France ; and</note>
								<orgName type="laboratory" key="lab1">Lab-STICC</orgName>
								<orgName type="laboratory" key="lab2">UMR CNRS 6285</orgName>
								<orgName type="institution">IMT Atlantique</orgName>
								<address>
									<postCode>29238</postCode>
									<settlement>Brest</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yassine</forename><surname>El Ouahidi</surname></persName>
							<affiliation key="aff19">
								<note type="raw_affiliation"><label>20</label> IMT Atlantique , Lab-STICC , UMR CNRS 6285 , 29238 Brest , France ; and</note>
								<orgName type="laboratory" key="lab1">Lab-STICC</orgName>
								<orgName type="laboratory" key="lab2">UMR CNRS 6285</orgName>
								<orgName type="institution">IMT Atlantique</orgName>
								<address>
									<postCode>29238</postCode>
									<settlement>Brest</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Treçy</forename><surname>Gonçalves</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Eric</forename><surname>Vicaut</surname></persName>
							<affiliation key="aff20">
								<note type="raw_affiliation"><label>21</label> Unité de Recherche Clinique , Groupe Hospitalier Lariboisiere Fernand-Widal , Paris , Île-de-France , France</note>
								<orgName type="department">Unité de Recherche Clinique</orgName>
								<orgName type="institution">Groupe Hospitalier Lariboisiere Fernand-Widal</orgName>
								<address>
									<settlement>Paris Île-de-France</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jean-Guillaume</forename><surname>Dillinger</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Solenn</forename><surname>Toupin</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Théo</forename><surname>Pezel</surname></persName>
							<email>theo.pezel@aphp.fr</email>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Cardiology , University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris , AP-HP) , Université Paris-Cité , Inserm MASCOT UMRS 942 , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="laboratory">AP-HP)</orgName>
								<orgName type="institution" key="instit1">University Hospital of Lariboisiere (Assistance Publique des Hôpitaux de Paris</orgName>
								<orgName type="institution" key="instit2">Université Paris-Cité</orgName>
								<orgName type="institution" key="instit3">Inserm MASCOT UMRS</orgName>
								<address>
									<addrLine>942 2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<note type="raw_affiliation"><label>4</label> DATA-TEMPLE Laboratory , Department of Data Science , Machine Learning and Artificial Intelligence in Health , University Hospital of Lariboisiere (AP-HP) , 2 Rue Ambroise Paré , 75010 Paris , France;</note>
								<orgName type="department" key="dep1">Department of Data Science</orgName>
								<orgName type="department" key="dep2">Machine Learning and Artificial Intelligence in Health</orgName>
								<orgName type="laboratory">DATA-TEMPLE Laboratory</orgName>
								<orgName type="institution">University Hospital of Lariboisiere (AP-HP)</orgName>
								<address>
									<addrLine>2 Rue Ambroise Paré</addrLine>
									<postCode>75010</postCode>
									<settlement>Paris</settlement>
									<country>France;</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Addict-Iccu</forename><surname>Investigators</surname></persName>
						</author>
						<title level="a" type="main" xml:id="_88a7MCp">Machine learning score to predict in-hospital outcomes in patients hospitalized in cardiac intensive care unit</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2024-12-20">20 December 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">2F524CEEC8879A69E0C647E52280ACFC</idno>
					<idno type="DOI">10.1093/ehjdh/ztae098</idno>
					<note type="submission">Received 24 July 2024; revised 3 October 2024; accepted 5 November 2024;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T12:14+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_vkQvTU9">Machine learning</term>
					<term xml:id="_NSmvcbH">Intensive cardiac care unit</term>
					<term xml:id="_2hnkxDa">Echocardiography</term>
					<term xml:id="_nvXpDVs">Outcomes</term>
					<term xml:id="_UBAnBmb">Death</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_62d3Th9">Aims</head><p xml:id="_UWSv5QE"><s xml:id="_2qq94Xr">Although some scores based on traditional statistical methods are available for risk stratification in patients hospitalized in cardiac intensive care units (CICUs), the interest of machine learning (ML) methods for risk stratification in this field is not well established.</s><s xml:id="_6EzahGt">We aimed to build an ML model to predict in-hospital major adverse events (MAE) in patients hospitalized in CICU.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bJ3hy2n">Methods and results</head><p xml:id="_q9gEjVh"><s xml:id="_FMkQpny">In April 2021, a French national prospective multicentre study involving 39 centres included all consecutive patients admitted to CICU.</s><s xml:id="_zhErW7x">The primary outcome was in-hospital MAE, including death, resuscitated cardiac arrest, or cardiogenic shock.</s><s xml:id="_bgywQ4p">Using 31 randomly assigned centres as an index cohort (divided into training and testing sets), several ML models were evaluated to predict in-hospital MAE.</s><s xml:id="_d9zHHM7">The eight remaining centres were used as an external validation cohort.</s><s xml:id="_bj4fub3">Among 1499 consecutive patients included (aged 64 ± 15 years, 70% male), 67 had in-hospital MAE (4.3%).</s><s xml:id="_wFsDpjb">Out of 28 clinical, biological, ECG, and echocardiographic variables, seven were selected to predict MAE in the training set (n = 844).</s><s xml:id="_KBC7vvC">Boosted cost-sensitive C5.0 technique showed the best performance compared with other ML methods [receiver operating characteristic area under the curve (AUROC) = 0.90, precision-recall AUC = 0.57, F1 score = 0.5].</s><s xml:id="_BxgbbWR">Our ML score showed a better</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="793.701"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_eteAWHP">Trial Registration</head><p xml:id="_kUHBjee"><s xml:id="_QG7xQC4">ClinicalTrials.gov</s><s xml:id="_b7VbqhA">Identifier: NCT05063097.</s></p><p xml:id="_SqVaU9z"><s xml:id="_7BCKr5b">- <ref type="figure">--------------------------------------------------------------------------------------------------------------------------------------------------------------</ref>Graphical Abstract</s></p><p xml:id="_rqGfNM2"><s xml:id="_ARFCaaM">1.0 1.0 0.8 0.6 0.6 0.4 0.4 0.2 0.2 0.0 0.0 0.8 Variables included in the ML model Illicit drug use Mean arterial pressure Killip stage Exhaled CO level LVEF TAPSE value Peak E/e' ratio Sensitivity 1-Specifity ML model: AUROC 0.90 in index cohort, 0.88 in validation cohort qSOFA TIMI GRACE Acute HF ML model Logistic regression Traditional model 0.51 0.56 0.52 0.65 0.90 0.84 0.82</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_aGEvKp7">Introduction</head><p xml:id="_ktdKycP"><s xml:id="_jqRYWFv">Machine learning (ML) is a subdomain of artificial intelligence, where a model is trained to produce predictions, using a large quantity of generally multivariable data. <ref type="bibr" target="#b0">1</ref> The large amount of information to be processed in the medical setting makes it an optimal domain for the use of artificial intelligence methods.</s><s xml:id="_FBESqmg">ML techniques handle the complexity of the available data optimizing predictive performance and decisionmaking in several diseases. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref></s><s xml:id="_a9qBRw4">In the field of cardiovascular health in recent years, ML has been shown to be of particular interest. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s xml:id="_k95FfDx">ardiovascular imaging is particularly suited to these techniques because of the large amount of data to be processed, as recently studied by our working group. <ref type="bibr" target="#b5">6</ref></s><s xml:id="_EaK8dVS">he mortality rate for patients hospitalized in cardiac intensive care units (CICUs) has been estimated at 5-8%, which is not negligible.</s><s xml:id="_h23kVsY">For the clinician, risk stratification and prediction are important to adapt clinical and biological monitoring.</s><s xml:id="_vazBf3u">The ability of ML to integrate multimodal clinical, biological, electrocardiographic, and echocardiographic data seems of particular interest in the critical care setting. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref></s><s xml:id="_ruGZzQU">owever, risk stratification using ML techniques in CICU has been poorly evaluated. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_ZrqyGbP">herefore, this study aimed to assess the feasibility and performance of a ML-based score, through a large multicentre registry of consecutive patients admitted to CICU, to predict in-hospital major adverse event (MAE).</s><s xml:id="_xxK4k4f">The performance of this ML score will then be compared with existing scores and evaluated in an external validation cohort.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qmSdErM">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ApXwMPp">Study population</head><p xml:id="_z7n4kmz"><s xml:id="_qBHDVsS">The ADDICT-CICU study is a prospective, multicentre cohort study evaluating the prevalence of psychoactive drug use and its prognostic impact in patients hospitalized for acute cardiac events.</s><s xml:id="_zqT53VX">The study design of the ADDICT-CICU has been described in details previously. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_BMnDHSJ">In summary, all consecutive adults admitted to CICUs for 2 weeks in April 2021 among 39 centres across France were included.</s><s xml:id="_YwtEDTz">Cardiac intensive care units are units that allow hospitalization of all patients with acute cardiovascular disease including acute coronary syndrome (ACS), acute heart failure (HF), and other cardiovascular emergencies.</s><s xml:id="_MxtUTsP">The list of participating centres is provided in Supplementary material online, Methods S1.</s><s xml:id="_Un2BaKq">The inclusion criteria were as follows: male or female patients aged ≥18 years admitted to the CICU whatever the medical reason with a written informed consent obtained at enrolment.</s><s xml:id="_xDmut8U">The management of each patient was at the discretion of the treating physicians following the current European Society of Cardiology guidelines. <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref></s><s xml:id="_Jm3brqs">2]<ref type="bibr" target="#b12">[13]</ref> This study was approved by the Ethics Committee (Committee for the Protection of Human Subjects, Ile de France-7, France) and registered on the Clinicaltrials.gov</s><s xml:id="_AR6hxpu">website under the number NCT05063097.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wac7BFZ">Baseline characteristics collection</head><p xml:id="_UfU8uSw"><s xml:id="_MhWMkbB">All details regarding baseline characteristics collection were already published. <ref type="bibr" target="#b9">10</ref></s><s xml:id="_KM6XmEa">Briefly, baseline data included clinical, reason for hospitalization, list of medications, especially cardiovascular drugs at admission, and history of cardiovascular disease.</s><s xml:id="_njj7sZD">Haemodynamic was evaluated using non-invasive measurement of arterial pressure.</s><s xml:id="_fP2XvXq">Transthoracic echocardiography was performed systematically within the first 24 h of admission for all patients (all standardized echocardiographic parameters are presented in the Supplementary material online, Methods S3).</s><s xml:id="_SqWvZTm">Biological data were collected systematically upon admission, including haemoglobin, serum potassium, creatinaemia, the peak of troponin, the N-terminal prohormone of B-type natriuretic peptide, or B-type natriuretic peptide.</s></p><p xml:id="_G784E9V"><s xml:id="_NC2XQQ3">The presence of illicit drugs was determined through urine analysis using a dedicated drug assay (NarcoCheck®, Kappa City Biotech SAS, Montluçon, France) within 2 h of admission to the CICU.</s><s xml:id="_3KmWWcR">The following illicit drugs will be screened for all consecutive patients: (i) cannabinoids (tetrahydrocannabinol), including cannabis and hashish; (ii) cocaine and metabolites, including cocaine and crack; (iii) amphetamines; (iv) 3,4methylenedioxy-methylamphetamine (or ecstasy); and (v) heroin and other opioids.</s><s xml:id="_43frh8h">The NarcoCheck® urine drug assay detected the following medical psychoactive drugs: barbiturates, benzodiazepines, tricyclic antidepressant drugs, methadone, and buprenorphine (see Supplementary material online, Methods S2).</s><s xml:id="_NHBT223">A standardized exhaled carbon monoxide (CO) measurement was systematically taken with a CO-Check Pro device (Micro Direct Diagnostics Ltd, UK) immediately on arrival in CICU.</s><s xml:id="_U22FwUX">The threshold of &gt;10 parts per million was used to signify an active smoking. <ref type="bibr" target="#b13">14</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_38KGksc">Primary outcome</head><p xml:id="_b29RGUU"><s xml:id="_VKC8sP9">The primary outcome was in-hospital MAE defined as a composite of all-cause in-hospital mortality, cardiogenic shock (requiring medical or mechanical haemodynamic support), and resuscitated cardiac arrest (severe ventricular arrhythmia requiring defibrillation or anti-arrhythmic agents).</s><s xml:id="_YGssdSF">All events, included in-hospital MAE, were adjudicated by an independent committee of experts who reviewed anonymized medical documents according to standardized definitions. <ref type="bibr" target="#b14">15</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ZVyCeBD">Data preprocessing</head><p xml:id="_jbrbhzW"><s xml:id="_T5rDz3f">Various data preprocessing approaches were investigated within the scope of this study.</s><s xml:id="_kqcj8Ab">The data set underwent manipulation through diverse methodologies aimed at assessing and enhancing algorithmic performance.</s><s xml:id="_jMaSsWP">Initially, the primary data set was adjusted to exclude patients with missing data, and no preprocessing steps were applied.</s><s xml:id="_sRrduu5">The primary findings were based on this approach.</s><s xml:id="_xnBCMXe">In the second approach, we imputed missing values using the multivariate imputation by chained equations method (R package: mice).</s><s xml:id="_XEfr7YD">Finally, to address imbalanced date (low prevalence of events), we used a third strategy of data resampling with the synthetic minority oversampling technique algorithm (R package: DMwR).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Pp7faa3">Model selection and evaluation</head><p xml:id="_qR3AxNy"><s xml:id="_pARXB89">In the context of imbalanced data (a large number of patients for a small number of events), a comparative analysis was conducted among logistic regression and alternative supervised ML algorithms (including ridge regression, boosted cost-sensitive C5.0, and XGBoost).</s><s xml:id="_BRGVm8s">While logistic regression faces challenges with imbalanced data, ridge regression introduces regularization to mitigate overfitting.</s><s xml:id="_NXX3rhu">Boosted cost-sensitive C5.0 adapts the C5.0 decision tree algorithm by incorporating cost-sensitive considerations, assigning different misclassification costs to minority and majority classes.</s><s xml:id="_TR3rWB2">XGBoost, an ensemble method, employs a gradient boosting framework and is well suited for handling class imbalances through adaptive boosting of weak learners.</s><s xml:id="_D38PR5m">Adaptive boosting is an artificial intelligence technique that optimizes the performance of an algorithm by using a number of weaker and less efficient algorithms in combination.</s><s xml:id="_xu23c7g">By combining these weaker algorithms, a more powerful model can be built.</s><s xml:id="_j8pcRzU">The same principle can also be used to combine complex algorithms and improve their accuracy.</s><s xml:id="_nZenNAb">In addressing imbalanced data, the aim is therefore to minimize the overall misclassification cost and mitigate the problem of imbalanced data.</s><s xml:id="_cwVN3Fn">To assess the performance of these algorithms, we used several parameters: AUROC, precision-recall area under curve (PRAUC), balanced accuracy, F1 score, sensitivity, specificity, positive and negative prediction values, McNemar test P-value, and Brier score.</s><s xml:id="_5vjG7X2">Due to the low occurrence of events and the imbalanced nature of the data, the F-score and the precision-recall curve were preferred to determine the best model.</s><s xml:id="_TMznvjB">We used a five-fold cross-validation process to fit the model hyperparameters using grid search (R package: caret).</s></p><p xml:id="_Fjbuk6Z"><s xml:id="_pGRsXAw">To evaluate the interest of the CICU classification model, the performance of the proposed ML model will be compared to a logistic regression with variables selected a priori according to their clinical pertinence including age, sex, body mass index, hypertension, diabetes and LVEF, and known scores assessing outcomes in CICU patients from the literature: quick Sequential Organ Failure Assessment (qSOFA), Thrombolysis In Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), and the Acute Heart Failure (ACUTE-HF) score. <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref></s><s xml:id="_g5bnPWF">9]<ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref> (see Supplementary material online, Methods S4)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CB88Us8">Statistical analysis</head><p xml:id="_pVdFS3j"><s xml:id="_JAUNkAa">Continuous data are reported as mean ± standard deviation for normally distributed data or as medians and interquartile range for non-normally distributed data.</s><s xml:id="_24sPV4m">Categorical data are reported as counts and percentages.</s><s xml:id="_BC7vE7q">The normality of the variables was verified by histograms, quantile-quantile plot, and Shapiro-Wilk test.</s><s xml:id="_6txCmF5">Between-group comparisons were made using the Student's t-test or Mann-Whitney test for continuous variables and the χ 2 or Fisher's exact test for categorical variables, as appropriate.</s><s xml:id="_RGZcW5c">DeLong's test was used to compare the AUROC of the ML model and scores used in CICU. <ref type="bibr" target="#b21">22</ref></s><s xml:id="_EExgW4C"> two-tailed P-value &lt;0.05 was considered statistically significant.</s><s xml:id="_tKwgEde">All data were analysed using R software, version 3.6.3</s><s xml:id="_Byu4GwV">(R Project for Statistical Computing, R Foundation, Vienna, Austria).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dgMkrB4">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3rc7ATb">Study population</head><p xml:id="_wr9GYQc"><s xml:id="_hTy8JwS">Out of 1499 patients included, 1205 (80%) constituted the index cohort, corresponding to the randomly selected 31 centres (Figure <ref type="figure" target="#fig_1">1</ref>).</s><s xml:id="_pUBPnFR">Patients were mostly men (70.3%) aged 63.5 ± 14.9 years, with one in four being obese (24.4%).</s><s xml:id="_Ks8prNm">In the index cohort, hypertension (53.8%) was the most frequent cardiovascular risk factor followed by dyslipidaemia (39.9%) and smoking (39.5%).</s><s xml:id="_H5dKKTC">Fifty-five patients (4.6%) presented with in-hospital MAE, including 19 (1.6%) in-hospital deaths, 14 (1.2%) cardiac arrest events, and 33 (2.7%) cardiogenic shocks requiring medical and/or mechanical haemodynamic support.</s><s xml:id="_nxuHgKx">Among the 19 in-hospital deaths, 12 patients died due to ventricular arrhythmias identified on the ECG scope after adjudication by an independent centralized committee.</s><s xml:id="_f7FA6jb">Baseline characteristics of subjects according to the onset of MAE are given in Table <ref type="table">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_tvDRR9e">Feature selection</head><p xml:id="_n25XhG5"><s xml:id="_V6RwXuP">Using the Boruta feature selection method, seven of the available variables were selected for the ML model (four clinical and three echocardiographic parameters): illicit drug use, mean arterial pressure, Killip class, exhaled CO level, LVEF, TAPSE value, and peak E/e′ ratio (Figure <ref type="figure" target="#fig_4">2</ref>).</s><s xml:id="_ubMUUNm">Tricuspid annular plane systolic excursion value and exhaled CO level were the two highest ranked features for in-hospital MAE prediction (see Supplementary material online, Figure <ref type="figure" target="#fig_1">S1</ref>).</s><s xml:id="_MkjjnBq">No differences were observed in the training and internal validation seta with respect to any of the above seven variables (see Supplementary material online, Table <ref type="table">S4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RVFuZtc">Prediction of in-hospital major adverse events</head><p xml:id="_4e3CsUV"><s xml:id="_MPBNrkQ">Boosted cost-sensitive C5.0 algorithm showed the AUROC: 0.90 [95% confidence interval (CI): 0.75-0.98]</s><s xml:id="_rYKZySb">compared with logistic regression (AUROC = 0.84; 95% CI: 0.72-0.96),</s><s xml:id="_ZEfdFgu">ridge regression (AUROC:0.85;</s><s xml:id="_FRCG6J6">95% CI: 0.72-0.96),</s><s xml:id="_j5kzSwQ">and XGBoost (AUROC: 0.83; 95% CI: 0.71-0.95)</s><s xml:id="_Mzn7M4G">techniques.</s><s xml:id="_byU2VHx">When assessed using PRAUC or F-score, boosted cost-sensitive C5.0 algorithm still showed better performance compared with other ML techniques, as given in Table <ref type="table">2</ref>. Detailed ROC and PR curves comparing ML techniques and logistic regression are available in Supplementary material online, Figure <ref type="figure" target="#fig_4">S2</ref>.</s><s xml:id="_zVvFdeQ">In a sensitivity analysis based on a resampled data set (offsetting the low number of events), boosted cost-sensitive C5.0 algorithm still showed the best performance.</s><s xml:id="_cTgMBrf">(see Supplementary material online, Figure <ref type="figure" target="#fig_6">S3</ref>).</s><s xml:id="_dm5bav6">The optimal hyperparameters were number of boosting iterations = 20, model type = tree, cost = 1, and no winnow.</s><s xml:id="_jDGqJcR">For illustrative purpose only, the most accurate tree with the lowest margin of error (3.4%) was extracted from the C5.0 model (Figure <ref type="figure" target="#fig_6">3</ref>).</s><s xml:id="_8g8esrC">Calibration plot showed good agreement between ML classification and the . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</s><s xml:id="_TWTWBzF">Table 1 Baseline characteristics according to the onset of in-hospital major adverse events in the index cohort (n = 1205) Index cohort (n = 1205) No MAE (n = 1150) MAE (n = 55) P-value Demographics Age, years (mean ± SD) 63.5 ± 14.9 63.5 ± 14.7 64.6 ± 17.4 0.64 Men 847 (70.3) 810 (70.4) 37 (67.3)</s><s xml:id="_89PeYPe">0.73 BMI, kg/m² (mean ± SD) 27.2 ± 5.5 27.3 ± 5.5 26.2 ± 5.0 0.13 Cardiovascular risk factors Diabetes 262 (21.7) 248 (21.6) 14 (25.5)</s><s xml:id="_gqJFQMN">0.61 Hypertension 648 (53.8) 619 (53.8) 29 (52.7)</s><s xml:id="_rsYaQwk">0.98 Dyslipidaemia 481 (39.9) 462 (40.2) 19 (34.5) 0.49 Current smoker 306 (25.4) 282 (24.5) 24 (43.6)</s><s xml:id="_RRnPpYf">&lt;0.001 Known CAD 405 (33.6) 387 (33.7) 18 (32.7)</s><s xml:id="_JscnaeY">1.0 Family history of CAD 201 (16.7) 198 (17.2) 3 (5.5)</s><s xml:id="_DVVfCPg">0.04 COPD 51 (4.2) 49 (4.3) 2 (3.6) 1.0 Asthma 14 (1.2) 13 (1.1) 1 (1.8) 0.48 Medical history of non-cardiovascular disease Cancer 53 (4.40) 49 (4.26) 4 (7.27)</s><s xml:id="_74sbj7s">0.19 Psychiatric history 120 (9.96) 112 (9.74) 8 (14.5) 0.35 Admission diagnosis STEMI 270 (22.4) 254 (22.1) 16 (29.1)</s><s xml:id="_CbRakDp">0.29 NSTEMI 355 (29.5) 342 (29.7) 13 (23.6)</s><s xml:id="_jtK7W2C">0.41 Acute HF 179 (14.9) 163 (14.2) 16 (29.1)</s><s xml:id="_WkwMckE">0.004 Arrhythmia 74 (6.1) 72 (6.3) 2 (3.6) 0.57 Myocarditis or pericarditis 56 (4.7) 55 (4.8) 1 (1.8) 0.51 Cardiac conduction abnormalities 65 (5.4) 64 (5.6) 1 (1.8) 0.36 Pulmonary embolism 33 (2.7) 33 (2.9) 0 (0.0) 0.40 Others a 173 (14.4) 167 (14.5) 6 (10.9) 0.57 Clinical parameters at admission Mean arterial pressure, mmHg (mean ± SD) 98 ± 18 99 ± 17 88 ± 20 &lt;0.001 Heart rate, b.p.m. (mean ± SD) 82 ± 24 82 ± 24 89 ± 28 0.08 Oxygen saturation, % (mean ± SD) 97.0 ± 5.6 97.0 ± 5.7 96.9 ± 2.7 0.69 Killip class &lt;0.001</s><s xml:id="_xQWX3z3">I 996 (82.7) 964 (83.8) 32 (58.2) II 136 (11.3) 124 (10.8) 12 (21.8)</s><s xml:id="_MhgKHFZ">&gt;III 70 (5.81)</s><s xml:id="_2tPg9ZX">59 (5.13) 11 (20.0)</s><s xml:id="_drrECBM">Biological parameters at admission (mean ± SD) Haemoglobin, g/dL 13.5 ± 2.0 13.5 ± 1.9 12.9 ± 2.5 0.08 Creatinaemia, µmol/L 98 ± 72 97 ± 72 111 ± 61 0.11 High-sensitivity cardiac troponin peak, Ul/L [median (IQR)] 11.2 (1.75; 169) 10.6 (1.69; 155) 98.2 (2.96; 644) 0.53 NTproBNP, pg/mL [median (IQR)] 2555 (599; 11 251) 2451 (594; 11 170) 8537 (1007; 15 273) 0.03 Echocardiographic data LV dilatation ≥ 75 mL/m 2 114 (9.5) 110 (9.6) 4 (7.3)</s><s xml:id="_Ssshmct">0.74 LA dilatation ≥ 32 mL/m 2 222 (18.4) 201 (17.5)</s><s xml:id="_8xSvgNh">21 (38.2) &lt;0.001 Ratio E/A (mean ± SD) 1.1 ± 0.6 1.1 ± 0.6 1.4 ± 0.6 0.008 Ratio E/e′ &gt; 14 113 (9.4) 99 (8.6) 14 (25.5)</s><s xml:id="_M8w4hw6">&lt;0.001 Ratio E/e′ (mean ± SD) 9.1 ± 4.1 8.8 ± 3.8 13.3 ± 5.7) &lt;0.001 LVEF ≤ 25% 82 (6.8) 71 (6.2) 11 (20.0)</s><s xml:id="_4Xj4pGg">&lt;0.001 LVEF (mean ± SD) 52.2 ± 13.2 52.7 ± 12.8 42.1 ± 17.3 &lt;0.001 LVOT VTI (mean ± SD) 19. ± 5 20 ± 5 16 ± 6 &lt;0.001 sPAP (mean ± SD) 35.2 ± 14.1 34.6 ± 13.9 44.6 ± 13.7 &lt;0.001 RV dilatation 79 (6.6) 71 (6.2) 8 (14.5) 0.02 TAPSE ≤ 17 mm 178 (14.8) 166 (14.4) 12 (21.8)</s><s xml:id="_Abhbn4V">&lt;0.001 Continued observed in-hospital risk of MAE (see Supplementary material online, Figure <ref type="figure" target="#fig_7">S4</ref>).</s></p><p xml:id="_GSCCXYC"><s xml:id="_ppjeKN9">Receiver operating characteristic and PR curves comparing the ML model to previously existing CICU scores are shown in Figure <ref type="figure" target="#fig_7">4</ref>.</s><s xml:id="_YZT8TzG">The prediction performance of the ML model (AUROC: 0.90) was significantly superior to that of the quick Sequential Organ Failure Assessment (qSOFA) (AUROC: 0.51, P &lt; 0.001), TIMI (AUROC: 0.56, P = 0.005), GRACE (AUROC: 0.52, P = 0.001), and ACUTE-HF (AUROC: 0.65, P = 0.017) scores.</s><s xml:id="_uTkSsJh">Machine learning model also showed improved performance compared with a traditional logistic regression model (AUROC: 0.90 vs. 0.82, respectively, P = 0.032).</s><s xml:id="_xTTdFrH">A sensitivity analysis conducted in the subgroup of patients with HF (n = 179) confirmed that the ML model also outperformed ACUTE-HF score (AUROC: 0.89 vs. 0.60, P = 0.002 and PRAUC: 0.56 vs. 0.17) (see Supplementary material online, Figure <ref type="figure">S5</ref>).</s><s xml:id="_uHUYErs">Similar results were found in the ACS subgroup (n = 625): ML model showed improved prediction performance compared with TIMI and GRACE scores (AUROC: 0.94 vs. 0.51 and 0.64, respectively, P &lt; 0.001 and PRAUC: 0.61 vs. 0.22 and 0.17, respectively) (see Supplementary material online, Figure <ref type="figure">S6</ref>)</s></p><p xml:id="_J8Y8TsZ"><s xml:id="_7rsfD9D">No difference was found according to the admission in university vs. non-university hospitals (AUROC: 0.88 vs. 0.91, respectively, P = 0.08; and PRAUC: 0.55 vs. 0.58, respectively, P = 0.07).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_nvXAxZR">Validation of the machine learning model in the independent cohort</head><p xml:id="_nABB48m"><s xml:id="_UzPjcU9">Out of 294 patients included in eight independent centres, 12 (4.1%)</s><s xml:id="_Ves4jGn">presented MAE, with no significant difference compared with the index cohort (4.6% of in-hospital MAE, P = 0.84).</s><s xml:id="_SfduRM5">The independent validation cohort was similar to the index cohort regarding demographics (66.7% men, aged 62.2 ± 15.1 years), cardiovascular risk factors, and medical history.</s><s xml:id="_6u3zFEW">Characteristics of the independent validation cohort compared with the index cohort are detailed in Supplementary material online, Table <ref type="table">S5</ref>.</s></p><p xml:id="_D3Bdq3P"><s xml:id="_Fcwv9CC">Our proposed ML model, assessed in the independent validation cohort, presented similar AUROC compared with the index cohort (AUC: 0.88 vs. 0.90, respectively).</s><s xml:id="_TaU5AYz">Consistently, the ML model exhibited a higher AUROC in the independent cohort compared with qSOFA, TIMI, GRACE, ACUTE-HF score, and a traditional logistic regression model (ML: 0.88 vs. qSOFA: 0.50, TIMI: 0.73, GRACE: 0.71, ACUTE-HF: 0.61, logistic regression: 0.86).</s><s xml:id="_PHfqGCY">Similar results were found regarding PRAUC (see Supplementary material online, Figure <ref type="figure">S7</ref>).</s><s xml:id="_h7a3yk2">Killip class, exhaled CO level, LVEF, TAPSE value, and peak E/e′ ratio.</s><s xml:id="_NNAFaKY">It showed greater prognostic value to predict in-hospital outcomes than several traditional scores, including qSOFA, TIMI, GRACE, and ACUTE-HF, with similar performance in an external validation cohort.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_33nY4Pt">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BvjD8j8">Table 1 Continued</head><p xml:id="_6P22Hxh"><s xml:id="_yEWCRzj">In our study, we reported a rate of in-hospital MAE of 4.6% and inhospital death of 1.6%.</s><s xml:id="_8BUXERY">Prior American and Canadian studies have shown a higher death rate estimated around 8.5% in overall patients hospitalized in CICU. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref></s><s xml:id="_6Bbq7Xk">In parallel, studies conducted in coronary intensive care unit including mainly ACSs showed death rates closer to our study around 4.5%. <ref type="bibr" target="#b24">25</ref></s><s xml:id="_x6e5Aya">However, we observed baseline demographic features highly similar to that of prior CICU populations with a vast majority of men and a mean age around 65 years. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b25">26</ref></s><s xml:id="_Uchc6kq">This low rate of in-hospital death in our study could then be related to the high proportion of ACSs in the ADDICT-CICU trial.</s><s xml:id="_HX6bDPs">It has been shown that death and adverse events among patients hospitalized for ACS have decreased over the past decades and remain lower than that of patients admitted for acute HF. <ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref> Exhaled CO was one of the highest ranked features for risk prediction in our analysis.</s><s xml:id="_Q59t7fJ">It has been previously described as a measure of particular interest for the study of tobacco exposure and is used in the monitoring of smoking cessation. <ref type="bibr" target="#b13">14</ref></s><s xml:id="_hkdMTRF"> Table 2 Supervised learning machine algorithms to predict in-hospital major adverse events Model evaluation metrics Logistic regression Ridge regression Boosted C5.0 XGBoost AUROC (95% CI) 0.84 (0.72-0.96) 0.85 (0.72-0.96) 0.90 (0.75-0.98) 0.83 (0.71-0.95) Precision-recall AUC 0.53 0.54 0.57 0.42 Balanced accuracy 0.66 0.66 0.70 0.62 F-score 0.42 0.42 0.50 0.33 Sensitivity 0.33 0.34 0.42 0.25 Specificity 0.98 0.98 0.99 0.99 Positive predictive value 0.57 0.57 0.63 0.50 Negative predictive value 0.97 0.96 0.97 0.96 McNemar test P-value 0.23 0.23 0.34 0.15 Brier score 0.91 0.9 0.68 0.95 CO, carbon monoxide; LVEF, ventricular ejection fraction; MAP, mean arterial pressure; TAPSE, Tricuspid annular plane systolic excursion.</s><s xml:id="_K7apXX9">and the occurrence of cardiovascular disease or metabolic syndrome, independent of smoking status. <ref type="bibr" target="#b27">28</ref></s><s xml:id="_DfYnneb">Our working group has already shown that exhaled CO, not only associated with the risk of developing cardiovascular disease, would also be associated with the in-hospital prognosis in the acute phase once the cardiovascular disease is declared. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b28">29</ref></s><s xml:id="_vsDY3Kv">This finding is also supported by Tun et al. <ref type="bibr" target="#b29">30</ref> who showed that increased levels of exhaled CO were associated with an adverse cardiovascular biomarker profile and a higher risk of HF, especially with reduced ejection fraction.</s><s xml:id="_gGVf2dD">Exhaled CO may therefore be an interesting predictive marker for acute HF as well as coronary artery disease through its association with a poor cardiovascular risk profile.</s><s xml:id="_Bb4bv3t">Illicit drug use was also integrated as an important variable to build our ML model.</s><s xml:id="_ny7yB8t">This finding is in line with a prior analysis from ADDICT-CICU study showing that illicit drug use is strongly associated with the occurrence of in-hospital outcomes with an incremental prognostic value above traditional risk factors. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_pp7n6dC">These findings can be explained by several types of sympathomimetic effects of illicit drugs which can increase blood pressure, heart rate, temperature, and consequently myocardial oxygen demand. <ref type="bibr" target="#b30">31</ref></s><s xml:id="_BxwMCrB">e observed a strong contribution of echocardiographic parameters to risk prediction.</s><s xml:id="_UDS8pCk">The three echocardiographic parameters retained in the variables of importance reflected left, right, and diastolic ventricular function with LVEF, TAPSE index, and E/e′ ratio.</s><s xml:id="_r7maA4v">Many studies have shown that left ventricular dysfunction, evaluated using global longitudinal strain or LVEF, was associated with a poor prognosis in a wide spectrum of cardiovascular diseases. <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref></s><s xml:id="_zCdvSjS">Right ventricular dysfunction in the acute setting of coronary syndrome and HF has also been described as an important prognostic factor. <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref></s><s xml:id="_ezKpjep">The same is true regarding prognostic significance of filling pressure, which was well known in HF and has recently been demonstrated in the field of ACSs. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_RMrjm2e">These findings are in line with a recent study which showed a specific association of the E/e' ratio with overall in-hospital death in CICU. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_kVrXFsK">ur ML model exhibited improved prognostic value to predict in-hospital outcomes than several traditional scores assessed in CICU, including traditional logistic regression.</s><s xml:id="_wfzmqru">Our ML model included only seven variables to outstripped GRACE and TIMI scores in ACS, and ACUTE-HF score in acute HF. <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b19">20</ref> These good performance could be partly explained by the many-faceted nature of the model: each variable captures a different facet of the patient's medical evaluation (i.e.</s><s xml:id="_GW4bPnf">haemodynamic, inotropism, fluid overload) that could have consequences on both the short and medium term.</s><s xml:id="_66UGrkB">Besides, the small number of variables ensures a practical and easy use in everyday practice.</s><s xml:id="_gEtBRMW">Up to date, no specific ML model including clinical, biological, and echocardiographic data has been built. <ref type="bibr" target="#b37">38</ref></s><s xml:id="_b9W8VWU">The Mayo Clinic team recently developed a clinicobiological risk model that does not include echocardiographic and ECG characteristics.</s><s xml:id="_7A8uUzK">The M-CICU Admission Risk Model (M-CARS) was also developed specifically for CICU patients. <ref type="bibr" target="#b38">39</ref></s><s xml:id="_amaVudq">he M-CARS model consists of seven variables, one of which is the Braden skin model and three are biological results (blood urea nitrogen, anion gap, and red blood cell distribution width).</s><s xml:id="_sWus9hH">Unfortunately, we did not have all the data necessary to calculate this model and could not compare the performance of our ML model with that of M-CARS.</s><s xml:id="_zFGBEu7">Most of the scores developed to date have produced good results using traditional statistical methods such as logistic regression.</s><s xml:id="_5fFrmDZ">Although our results show a better performance of the ML model, some data shade the interest of ML techniques in the prediction of medical risk.</s><s xml:id="_xr76jPt">Large systematic reviews suggest that, in the presence of bias, poor calibration, and/or other methodological limitations, ML often has no performance advantage over logistic regression models. <ref type="bibr" target="#b39">40</ref></s><s xml:id="_BZjPgfa">Larger external validation cohorts in other regions or other healthcare systems are needed to confirm the performance of the ML model.</s></p><p xml:id="_keWCESV"><s xml:id="_8tbCUz6">Interestingly, the ML model seems to distinguish two groups of patients.</s><s xml:id="_ANXE27g">On the one hand, right ventricular function of smokers is of particular interest.</s><s xml:id="_YjaVFGp">This result may be explained by the association of smoking with an increased incidence of respiratory diseases such as obstructive lung disease or elevated pulmonary pressures.</s><s xml:id="_pPdYz6w">The tree then differentiates the patients in this group as having or not having diastolic dysfunction, illustrating the possible evolution of right heart pathology on left pressures.</s><s xml:id="_Gg9Jt7T">Non-smoking patients, on the other hand, have a greater burden of HF and haemodynamic signs, with a thorough evaluation of signs of cardiogenic (pre-)shock.</s><s xml:id="_bdHEKGv">These results demonstrate other interests and advantages of ML techniques based on decision trees.</s><s xml:id="_SawBzGg">In fact, they can also be used to identify subgroups of patients with different risk profiles.</s><s xml:id="_3QVHB6C">Here, the subgroups identified by the ML model correspond to genuine patient populations with their own characteristics.</s><s xml:id="_MryhaAM">The machine learning model had a significantly higher area under the curve for receiver operating curves and precision-recall curves in predicting inhospital major adverse events than all other risk models (P &lt; 0.001).</s><s xml:id="_RKntctR">The results are given with their 95% confidence interval.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JftQf3j">Study limitations</head><p xml:id="_65tdAqK"><s xml:id="_ybVjzXC">We acknowledge some limitations.</s><s xml:id="_72syK43">First, the sample of patients analysed was reduced after splitting between training and validation cohorts.</s><s xml:id="_NZWpm24">In addition, the exclusion of eight centres to build an independent validation cohort also lowered the sample size.</s><s xml:id="_ckKzAWU">This implies that the subgroup of patients with the same hospitalization reason, such as HF or ACS, also had small sample size.</s><s xml:id="_keq4nuH">The performance of this ML score on these diagnostic subcategories should therefore be interpreted cautiously.</s><s xml:id="_YNrU9X5">Nevertheless, as there is no other study on the CICU population that has measured exhaled CO and illicit drug use, the results necessarily had to be validated on the ADDICT-CICU cohort.</s><s xml:id="_f85CHPF">Indeed, we acknowledge as a significant limitation the lack of external validation of our ML model outside of France.</s><s xml:id="_ChJWH68">Second, although we observed a small number of in-hospital events, we adapted our statistical analysis with algorithm and resampling techniques to deal with unbalanced data. <ref type="bibr" target="#b40">41</ref></s><s xml:id="_CXAMhVf">A specific post hoc sensitivity analysis was carried out for this purpose.</s><s xml:id="_9ZjQ2By">Although the high heterogeneity of the population of this study is a significant challenge and a limitation of the analysis, it is important to highlight similar performances of our ML score in the subgroup analyses performed.</s><s xml:id="_jXFhBmP">Third, we noted missing data on ultrasound variables, up to 25% for the E/e′ ratio, related to the feasibility of the examination in the acute phase.</s><s xml:id="_EpB3Khc">Although echocardiography is carried out at the patient's bedside, it is not always easy to perform within the first 24 h of admission in many centres around the world.</s><s xml:id="_w56fPM4">Still, the selection of variables was performed only on patients without missing data and a post hoc sensitivity analysis conducted in overall patients showed similar results.</s><s xml:id="_Wna9hQV">Fourth, our final model included illicit drug use and exhaled CO level, which are not routinely captured in all CICUs.</s><s xml:id="_6h4c4XQ">However, a growing body of evidence points to the value of systematically assessing drug use at CICU admission, and exhaled CO levels can help assess respiratory status.</s><s xml:id="_FkHD6cq">We also collected information on illicit drug use at the time of admission to hospital and on history of drug use, but we can neither establish nor rule out a causal link between drug use and hospitalization.</s><s xml:id="_hVt5Vp3">In addition, some biological data such as lactate dosage or interventional findings such as the frequency of the need for ventilation, organ replacement procedures, and/or SAPS/TISS were not systematically performed in the patients of this study due to the initial haemodynamic stability at baseline.</s><s xml:id="_hgtTw39">Fifth, although this was a multicentre study, it was not exhaustively conducted in all French centres.</s><s xml:id="_3ReYjHa">Yet, the 39 centres that participated in the study included centres in large metropolitan areas, medium-sized cities, public university hospitals, non-university hospitals, and private clinics, ensuring a fairly representative sample of French CICUs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_ttuWGuy">Conclusion</head><p xml:id="_mcjbPXV"><s xml:id="_UtqfGFC">Using data from a prospective multicentre cohort study, we built a ML model to predict in-hospital outcomes of patients admitted to CICU.</s><s xml:id="_JNVENYf">Based on few simple clinical and echocardiographic variables (illicit drug use, mean arterial pressure, Killip class, exhaled CO level, LVEF, TAPSE value, and peak E/e′ ratio) collected at admission, this ML model showed improved performance to predict in-hospital outcomes than several traditional scores, including the qSOFA, TIMI, GRACE, and ACUTE-HF scores.</s><s xml:id="_aUZc5xV">Finally, this ML score has been designed to be quick and easily feasible to facilitate early triage and target patients at high risk of clinical worsening.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1</head><label>1</label><figDesc><div><p xml:id="_Mz8Fvu7"><s xml:id="_NhmtsVQ">Figure 1 Flow chart of the study population.</s></p></div></figDesc><graphic coords="4,72.96,75.12,455.02,260.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc><div><p xml:id="_h5sXS58"><s xml:id="_Ae9R8tT">Using ML techniques in a prospective multicentre cohort study of consecutive patients admitted to CICU, we trained a model to predict inhospital outcome.</s><s xml:id="_My6DGca">This ML model was based on few simple clinical and echocardiographic variables: illicit drug use, mean arterial pressure, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>a</head><figDesc><div><p xml:id="_PaBaJfk"><s xml:id="_987N67q">Other admission diagnoses included: coronary spasm, Takotsubo, aortic dissection, spontaneous coronary dissection, chest pain without identified cardiac cause, and other cardiovascular or non-cardiovascular diagnosis.</s><s xml:id="_7dA6sUR">BMI, body mass index; CAD, coronary artery disease; HF, heart failure; LA, left atrium; LV, left ventricle; LVEF, left ventricular ejection fraction; LVOT VTI, left ventricular outflow tract velocity time integral; NSTEMI, non-ST elevation myocardial infarction; NTproBNP, N-terminal prohormone of brain natriuretic peptide; RV, right ventricle; SD, standard deviation; sPAP, systolic pulmonary artery pressure; STEMI, ST elevation myocardial infarction.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2</head><label>2</label><figDesc><div><p xml:id="_v5byGft"><s xml:id="_7YmAHpV">Figure 2 Feature selection using Boruta technique.</s><s xml:id="_ujYSTX5">The Boruta variable selection algorithm was applied to obtain the variables that contribute the most to the prediction of major adverse events.</s><s xml:id="_yYhkVGQ">Considering a confidence level with a P-value threshold of 0.05, seven variables were considered important: tricuspid annular plane systolic excursion, carbon monoxide level, mean arterial pressure, left ventricular ejection fraction, Killip class, and ratio E/e′.</s></p></div></figDesc><graphic coords="6,54.43,206.53,225.13,432.85" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><figDesc><div><p xml:id="_RwY839s"><s xml:id="_3qUtQZd">A subanalysis of patients from the Framingham cohort showed an association between exhaled CO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3</head><label>3</label><figDesc><div><p xml:id="_sRdNCes"><s xml:id="_2QcEyMC">Figure 3 Decision tree illustrating the machine learning model.</s><s xml:id="_mQHnswD">Boosted C5.0 model is based on the idea of adaptive boosting.</s><s xml:id="_FmSZdwh">The main objective is to combine several weak classifiers into a stronger one, while keeping the robustness to overfitting of the weak classifiers.</s><s xml:id="_uSVYF6Z">The classification tree with the lowest error (3.4%) is shown below.</s></p></div></figDesc><graphic coords="7,66.84,291.63,455.92,247.64" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 4</head><label>4</label><figDesc><div><p xml:id="_ycUr6Aw"><s xml:id="_X5tYzNx">Figure 4 Compared performances of our machine learning model and existing risk scores.</s><s xml:id="_x2zEhrx">(A) shows the receiver operating curves and (B) shows the precision-recall curves comparing the performances of our machine learning model, logistic regression (including the same variables as the machine learning model), a traditional model (clinical a priori regression model), and other existing scores in the internal validation data set of the index cohort.The machine learning model had a significantly higher area under the curve for receiver operating curves and precision-recall curves in predicting inhospital major adverse events than all other risk models (P &lt; 0.001).</s><s xml:id="_rj5AqkA">The results are given with their 95% confidence interval.</s></p></div></figDesc><graphic coords="8,72.51,75.12,455.92,174.22" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_Be2VWnM"><s xml:id="_n4K7AGm">Downloaded from https://academic.oup.com/ehjdh/article/6/2/218/7929557 by guest on 17 July 2025</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_ZUEVzpV"><s xml:id="_UMHrG8s">Feature selection is the first step in ML analysis and was conducted according to the PRIME check list.<ref type="bibr" target="#b15">16</ref></s><s xml:id="_bRpXe2A">A dedicated algorithm pre-evaluates the importance of the variables in explaining the desired phenomenon.</s><s xml:id="_ucQ47UC">Variables whose role in predicting the event exceeds 5% are selected for further development of the ML model.</s><s xml:id="_SfZmbKF">After excluding variables by collinearity criteria, 28 variables were considered for the Boruta variable selection algorithm (see Supplementary material online, TableS2): age, body mass index, sex, oxygen saturation, dyslipidaemia, left ventricle dilatation, psychiatric history, left atrium dilatation, heart rate, hypertension, family history of coronary artery disease, diabetes, alcohol consumption, active cancer, left ventricle dysfunction, right ventricle dilatation, N-terminal prohormone of brain natriuretic peptide, known coronary artery disease, creatinaemia, troponin peak, haemoglobin, drug consumption, ratio E/e′, Killip class, left ventricular ejection fraction (LVEF), mean arterial pressure, CO level, and tricuspid annular plane systolic excursion (TAPSE).</s><s xml:id="_Zw6kKfj">The Boruta process consists of adding randomness to a given data set by creating mixed copies of all features, called shadow features.<ref type="bibr" target="#b16">17</ref></s><s xml:id="_TNNmPm3">A random forest classifier applies feature importance measure to the augmented data set.</s><s xml:id="_pnJxPxJ">At each iteration, it tests whether the true feature is more important than its shadow feature, considering a P-value &lt; 0.05, and constantly removes unimportant features.</s><s xml:id="_yyCSCc6">Missing data in variables selected by the Boruta technique are given in Supplementary material online, TableS3.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_nnhWb3n"><s xml:id="_R6z84xQ">O. Weizman et al.</s><s xml:id="_q4uHJJU">Downloaded from https://academic.oup.com/ehjdh/article/6/2/218/7929557 by guest on 17 July 2025</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_8hTzFgc">Acknowledgements</head><p xml:id="_WtMYSz2"><s xml:id="_fKp47se">The authors would like to thank all the investigators of the centres for agreeing to participate in this study and the team of the '<rs type="institution">Unité de Recherche Clinique Fernand-Widal'</rs>, in particular <rs type="person">Brahim Mohamed Elarbi</rs>, for their help in the design and implementation of this study.</s></p></div>
			</div>
			<div type="funding">
<div><head xml:id="_Nn6dYQF">Funding</head><p xml:id="_qKcjH66"><s xml:id="_VmwzNxK">This research received an institutional grant from the '<rs type="funder">Fondation Coeur et Recherche</rs>, part of the <rs type="funder">French Society of Cardiology' (Paris, France)</rs>.</s><s xml:id="_mnU5vBu">Conflict of interest: J.-G.D. reports receiving consulting and lecture fees from <rs type="funder">AstraZeneca</rs>, <rs type="funder">Bayer</rs>, <rs type="funder">Boehringer-Ingelheim</rs>, <rs type="funder">Bristol-Myers Squibb/ Pfizer</rs>, <rs type="funder">Sanofi</rs>, and grants from <rs type="funder">Bayer</rs>, <rs type="funder">Bristol-Myers Squibb/Pfizer</rs>, and <rs type="funder">Biosensors</rs>.</s><s xml:id="_KkqEghT">T.P. reports receiving consulting and lecture fees from <rs type="funder">AstraZeneca</rs>, <rs type="funder">Bayer</rs>, and <rs type="funder">Bristol-Myers Squibb/Pfizer</rs> and <rs type="funder">General Electric</rs> and grants from <rs type="funder">Bayer</rs> and <rs type="funder">Servier</rs>.</s></p><p xml:id="_hWuUqxc"><s xml:id="_mUkSTgW">P.H. reports receiving consulting and lecture fees from <rs type="funder">AstraZeneca</rs>, <rs type="funder">Bayer</rs>, <rs type="funder">Boehringer-Ingelheim</rs>, <rs type="funder">Bristol-Myers Squibb/Pfizer</rs>, <rs type="funder">Sanofi</rs>, and <rs type="funder">Daiichi-Sankyo</rs> and grants from <rs type="funder">Bayer</rs>, <rs type="funder">Bristol-Myers Squibb/Pfizer</rs>, and <rs type="funder">Biosensors</rs>.</s><s xml:id="_3HWyJuA">All other authors report no conflict of interest.</s></p></div>
			</div>
			<listOrg type="funding">
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jFsTbDu">Data availability</head><p xml:id="_xReqjSj"><s xml:id="_Kfcke56">Data can be available upon request to the corresponding author.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KGhFJjv">Cohort split</head><p xml:id="_vsW8ez2"><s xml:id="_hPb95cj">The ADDICT-CICU trial contains specific variables such as CO level and illicit drug use using a systematic urinary assay that are difficult to find in other databases.</s><s xml:id="_sGjxy5H">To build an independent validation cohort and assess the reproducibility of the ML model, we selected centres from the ADDICTO-USIC trial.</s><s xml:id="_N3WBPth">Centres were randomly selected so that the total population of this cohort represented 20% of the ADDICTO-USIC trial population (8 centres, n = 294 patients), the remaining 80% constituting the index cohort (see Supplementary material online, Table <ref type="table">S1</ref>, 31 centres, n = 1205 patients).</s><s xml:id="_RaRYtNb">Then, several supervised ML models were trained on 70% of the patients in the index cohort (n = 844) using a single uniform random split at a patient level and subsequently evaluated on the remaining 30% for internal validation across all models (n = 361 patients).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8wP2FeG">Feature selection</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_h7QvnyP">Supplementary material</head><p xml:id="_yjp7ajb"><s xml:id="_Q8r5sCK">Supplementary material is available at European Heart Journal -Digital Health.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_2H4hah3">Machine learning in medicine</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Deo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uq8wWnu">Circulation</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="1920" to="1930" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Deo RC. Machine learning in medicine. Circulation 2015;132:1920-1930.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_uVtrm5B">Using machine learning and an ensemble of methods to predict kidney transplant survival</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Goldsman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gurbaxani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Keskinocak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sokol</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0209068</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7CEGurn">PLoS One</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">e0209068</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mark E, Goldsman D, Gurbaxani B, Keskinocak P, Sokol J. Using machine learning and an ensemble of methods to predict kidney transplant survival. PLoS One 2019;14: e0209068.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_cN7JM74">Application of machine learning in diagnosis of COVID-19 through X-ray and CT images: a scoping review</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mohammad-Rahimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nadimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ghalyanchi-Langeroudi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ghafouri-Fard</surname></persName>
		</author>
		<idno type="DOI">10.3389/fcvm.2021.638011</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_W4MpnGj">Front Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">638011</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mohammad-Rahimi H, Nadimi M, Ghalyanchi-Langeroudi A, Taheri M, Ghafouri-Fard S. Application of machine learning in diagnosis of COVID-19 through X-ray and CT images: a scoping review. Front Cardiovasc Med 2021;8:638011.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_wwFcRFf">Machine learning and the future of cardiovascular care: JACC state-of-the-art review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Quer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arnaout</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Henne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arnaout</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2020.11.030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_duYX3BK">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="300" to="313" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Quer G, Arnaout R, Henne M, Arnaout R. Machine learning and the future of cardiovas- cular care: JACC state-of-the-art review. J Am Coll Cardiol 2021;77:300-313.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_YGH6sBg">Artificial intelligence in cardiology</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Torres</forename><surname>Soto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Glicksberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Shameer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Miotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2018.03.521</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YpFTnHD">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="2668" to="2679" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johnson KW, Torres Soto J, Glicksberg BS, Shameer K, Miotto R, Ali M, et al. Artificial intelligence in cardiology. J Am Coll Cardiol 2018;71:2668-2679.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_GgNvcw2">Machine-learning score using stress CMR for death prediction in patients with suspected or known CAD</title>
		<author>
			<persName><forename type="first">T</forename><surname>Pezel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sanguineti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Garot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Unterseeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Champagne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Toupin</surname></persName>
		</author>
		<idno type="DOI">10.1093/ehjci/jeab289.437</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_shD5Zcx">JACC Cardiovasc Imaging</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1936878X" to="2200341211" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pezel T, Sanguineti F, Garot P, Unterseeh T, Champagne S, Toupin S, et al. Machine-learning score using stress CMR for death prediction in patients with sus- pected or known CAD. JACC Cardiovasc Imaging 2022;15:S1936878X2200341211.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_jy6YJur">Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Fleuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tlt</forename><surname>Klausch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Zwager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Schoonmade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Roggeveen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EzhYtGw">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="383" to="400" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fleuren LM, Klausch TLT, Zwager CL, Schoonmade LJ, Guo T, Roggeveen LF, et al. Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med 2020;46:383-400.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_X6fwdcP">Prediction model of in-hospital mortality in intensive care unit patients with heart failure: machine learning-based, retrospective analysis of the MIMIC-III database</title>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r2gK5B9">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">44779</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li F, Xin H, Zhang J, Fu M, Zhou J, Lian Z. Prediction model of in-hospital mortality in intensive care unit patients with heart failure: machine learning-based, retrospective analysis of the MIMIC-III database. BMJ Open 2021;11:e044779.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_EjRaWXM">Right Data Right Now Collaborators. Machine learning in intensive care medicine: ready for take-off?</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Fleuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Thoral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shillan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ercole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pwg</forename><surname>Elbers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g4DbBz6">Intensive Care Med</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1486" to="1488" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fleuren LM, Thoral P, Shillan D, Ercole A, Elbers PWG; Right Data Right Now Collaborators. Machine learning in intensive care medicine: ready for take-off? Intensive Care Med 2020;46:1486-1488.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_wXVfWaQ">Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: rationale and design of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of Cardiology</title>
		<author>
			<persName><forename type="first">J-G</forename><surname>Dillinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pezel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fauvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schurtz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trimaille</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.acvd.2022.05.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KxJCC8v">Arch Cardiovasc Dis</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page">187521362200155310</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dillinger J-G, Pezel T, Fauvel C, Delmas C, Schurtz G, Trimaille A, et al. Prevalence of psychoactive drug use in patients hospitalized for acute cardiac events: rationale and de- sign of the ADDICT-ICCU trial, from the Emergency and Acute Cardiovascular Care Working Group and the National College of Cardiologists in Training of the French Society of Cardiology. Arch Cardiovasc Dis 2022;115:S187521362200155310.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_rbkM7jd">ESC guidelines for the management of acute coronary syndromes</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Byrne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Rossello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Coughlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barbato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Berry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chieffo</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehad863</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bE5YaH8">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">19138</biblScope>
			<date type="published" when="2023">2023. 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guide- lines for the management of acute coronary syndromes. Eur Heart J 2023;44: ehad19138.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_BGggHYB">ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death</title>
		<author>
			<persName><forename type="first">K</forename><surname>Zeppenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tfelt-Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>De Riva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Winkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Behr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Blom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uqenqqc">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page">26240</biblScope>
			<date type="published" when="2022">2022. 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the preven- tion of sudden cardiac death. Eur Heart J 2022;43:ehac26240.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_kUdfkEk">ESC guidelines for the diagnosis and treatment of acute and chronic heart failure</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Mcdonagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Metra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adamo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Böhm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3sYjFU7">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">36836</biblScope>
			<date type="published" when="2021">2021. 2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:ehab36836.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_S46aXeg">Interpretation of exhaled CO levels in studies on smoking</title>
		<author>
			<persName><forename type="first">M</forename><surname>Underner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Peiffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SRWZCxM">Rev Mal Respir</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="293" to="300" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Underner M, Peiffer G. Interpretation of exhaled CO levels in studies on smoking. Rev Mal Respir 2010;27:293-300.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_zKpbbsp">ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Cardiovascular Endpoints Data Standards)</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Tcheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bozkurt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Chaitman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Cutlip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TxbWjp5">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="403" to="469" />
			<date type="published" when="2014">2014. 2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol 2015;66:403-469.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_yUTD6ZP">Proposed requirements for cardiovascular imaging-related machine learning evaluation (PRIME): a checklist: reviewed by the American College of Cardiology Healthcare Innovation Council</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Sengupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shrestha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Berthon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Messas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Donal</forename><forename type="middle">E</forename><surname>Tison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.jcmg.2020.07.015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gM4232U">JACC Cardiovasc Imaging</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2017" to="2035" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sengupta PP, Shrestha S, Berthon B, Messas E, Donal E, Tison GH, et al. Proposed re- quirements for cardiovascular imaging-related machine learning evaluation (PRIME): a checklist: reviewed by the American College of Cardiology Healthcare Innovation Council. JACC Cardiovasc Imaging 2020;13:2017-2035.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_jF3EaJf">Feature selection with the Boruta package</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Kursa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Rudnicki</surname></persName>
		</author>
		<idno type="DOI">10.18637/jss.v036.i11</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DMSgkCx">J Stat Softw</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1" to="1311" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kursa MB, Rudnicki WR. Feature selection with the Boruta package. J Stat Softw 2010; 36:1-1311.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_UyFvxVQ">The third international consensus definitions for sepsis and septic shock (sepsis-3)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Deutschman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Seymour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shankar-Hari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Annane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2016.0287</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M3JyKA4">JAMA</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="page" from="801" to="810" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 2016;315:801-810.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_TJr62uK">The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Antman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Pjlm</forename><surname>Bernink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Mccabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Horacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Papuchis</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.284.7.835</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S3qfjwU">JAMA</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page">835</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Antman EM, Cohen M, Bernink PJLM, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_gQ3cW2A">GRACE and GRACE2 Investigators. The global registry of acute coronary events, 1999 to 2009-GRACE</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Eagle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Steg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Anderson</surname></persName>
		</author>
		<idno type="DOI">10.1136/hrt.2009.190827</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_faChaCW">Heart Br Card Soc</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1095" to="1101" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA; GRACE and GRACE2 Investigators. The global registry of acute coronary events, 1999 to 2009-GRACE. Heart Br Card Soc 2010;96:1095-1101.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_7Yrx6cP">ACUTE HF score, a multiparametric prognostic tool for acute heart failure: a real-life study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cameli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Pastore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Carli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Henein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Mandoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Lisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mqSCeZd">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">296</biblScope>
			<biblScope unit="page" from="103" to="108" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cameli M, Pastore MC, De Carli G, Henein MY, Mandoli GE, Lisi E, et al. ACUTE HF score, a multiparametric prognostic tool for acute heart failure: a real-life study. Int J Cardiol 2019;296:103-108.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_nc6kHpj">Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Delong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Delong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Clarke-Pearson</forename><surname>Dl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4p6jYuk">Biometrics</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page">837</biblScope>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note type="raw_reference">DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_q65XqAS">Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the critical care cardiology trials network prospective north American multicenter registry of cardiac critical illness</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Bohula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Van Diepen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Alviar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Baird-Zars</forename><surname>Vm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-G</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamacardio.2019.2467</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FBNRvPC">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="928" to="935" />
			<date type="published" when="2019">2019. 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bohula EA, Katz JN, van Diepen S, Alviar CL, Baird-Zars VM, Park J-G, et al. Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the critical care cardiology trials network prospective north American multi- center registry of cardiac critical illness. JAMA Cardiol 2019 2019;4:928-935.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_HUJW7bq">Changes in primary noncardiac diagnoses over time among elderly cardiac intensive care unit patients in the United States</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Sjoding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sukul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Prescott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Iwashyna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Gurm</surname></persName>
		</author>
		<idno type="DOI">10.1161/circoutcomes.117.003616</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DJCAVKe">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">3616</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sinha SS, Sjoding MW, Sukul D, Prescott HC, Iwashyna TJ, Gurm HS, et al. Changes in primary noncardiac diagnoses over time among elderly cardiac intensive care unit pa- tients in the United States. Circ Cardiovasc Qual Outcomes 2017;10:e003616.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_PSwfNAq">National trends in coronary intensive care unit admissions, resource utilization, and outcomes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Woolridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Alemayehu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kaul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Fordyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Lawler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lemay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qEBpSBw">Eur Heart J Acute Cardiovasc Care</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="923" to="930" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Woolridge S, Alemayehu W, Kaul P, Fordyce CB, Lawler PR, Lemay M, et al. National trends in coronary intensive care unit admissions, resource utilization, and outcomes. Eur Heart J Acute Cardiovasc Care 2020;9:923-930.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_pHc3bZk">Description of acute cardiac care in 2014: a French nation-wide database on 277,845 admissions in 270 ICCUs</title>
		<author>
			<persName><forename type="first">F</forename><surname>Roubille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mercier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Manzo-Silberman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Leurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Elbaz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijcard.2017.04.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GQfhVFp">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="page" from="433" to="437" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roubille F, Mercier G, Delmas C, Manzo-Silberman S, Leurent G, Elbaz M, et al. Description of acute cardiac care in 2014: a French nation-wide database on 277,845 admissions in 270 ICCUs. Int J Cardiol 2017;240:433-437.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_wMZTUCq">In-hospital outcomes and long-term mortality according to sex and management strategy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) 2005 registry</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Donataccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Puymirat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Parapid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Steg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Eltchaninoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Weber</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijcard.2015.08.065</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7ab7BGm">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="265" to="270" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Donataccio MP, Puymirat E, Parapid B, Steg PG, Eltchaninoff H, Weber S, et al. In-hospital outcomes and long-term mortality according to sex and management strat- egy in acute myocardial infarction. Insights from the French ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) 2005 registry. Int J Cardiol 2015; 201:265-270.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_jsju5Ge">Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Enserro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Xanthakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Murabito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehu052</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vmR9EPT">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2980" to="2987" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng S, Enserro D, Xanthakis V, Sullivan LM, Murabito JM, Benjamin EJ, et al. Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. Eur Heart J 2014; 35:2980-2987.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_AgnRSzf">Prevalence and impact of recreational drug use in patients with acute cardiovascular events</title>
		<author>
			<persName><forename type="first">T</forename><surname>Pezel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-G</forename><surname>Dillinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Trimaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Delmas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Piliero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bouleti</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2023-322520</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_X9DCYKu">Heart Br Card Soc</title>
		<imprint>
			<biblScope unit="page" from="2023" to="322520" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pezel T, Dillinger J-G, Trimaille A, Delmas C, Piliero N, Bouleti C, et al. Prevalence and impact of recreational drug use in patients with acute cardiovascular events. Heart Br Card Soc;2023:heartjnl-2023-322520.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_HZb7H9a">Association of exhaled carbon monoxide with ideal cardiovascular health, circulating biomarkers, and incidence of heart failure in the Framingham offspring study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Tun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ehrbar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Short</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Vasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Xanthakis</surname></persName>
		</author>
		<idno type="DOI">10.1161/jaha.120.016762</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nafKUwS">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">16762</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tun B, Ehrbar R, Short M, Cheng S, Vasan RS, Xanthakis V. Association of exhaled car- bon monoxide with ideal cardiovascular health, circulating biomarkers, and incidence of heart failure in the Framingham offspring study. J Am Heart Assoc 2020;9:e016762.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_BnsZXwA">Cardiovascular complications of recreational drugs</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ghuran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Van Der Wieken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nolan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aCRSbyd">BMJ</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="464" to="466" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ghuran A, van Der Wieken LR, Nolan J. Cardiovascular complications of recreational drugs. BMJ 2001;323:464-466.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_TPKBbyk">Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes</title>
		<author>
			<persName><forename type="first">X</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Théroux</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2004.09.027</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8rJA7FX">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="215" to="220" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bosch X, Théroux P. Left ventricular ejection fraction to predict early mortality in pa- tients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2005;150: 215-220.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_ZCuqf8B">Left ventricular remodelling and prognosis after discharge in new-onset acute heart failure with reduced ejection fraction</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Berge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Vroegindewey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Veenis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Brugts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Caliskan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">C</forename><surname>Manintveld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_835zCfq">ESC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2679" to="2689" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Berge JC, Vroegindewey MM, Veenis JF, Brugts JJ, Caliskan K, Manintveld OC, et al. Left ventricular remodelling and prognosis after discharge in new-onset acute heart failure with reduced ejection fraction. ESC Heart Fail 2021;8:2679-2689.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_TcAYGFk">Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zehender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kauder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schönthaler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Geibel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olschewski</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejm199304083281401</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gBd4mP8">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">328</biblScope>
			<biblScope unit="page" from="981" to="988" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zehender M, Kasper W, Kauder E, Schönthaler M, Geibel A, Olschewski M, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myo- cardial infarction. N Engl J Med 1993;328:981-988.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_n8mmSvf">Right ventricular dysfunction predicts outcome in acute heart failure</title>
		<author>
			<persName><forename type="first">M</forename><surname>Berrill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ashcroft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fluck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Beeton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sharma</surname></persName>
		</author>
		<idno type="DOI">10.3389/fcvm.2022.911053</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b6SuACS">Front Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">911053</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Berrill M, Ashcroft E, Fluck D, John I, Beeton I, Sharma P, et al. Right ventricular dysfunc- tion predicts outcome in acute heart failure. Front Cardiovasc Med 2022;9:911053.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_6T5sTXn">E/e&apos; in relation to outcomes in ST-elevation myocardial infarction</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Tai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hamid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Amanullah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Fam</surname></persName>
		</author>
		<idno type="DOI">10.1111/echo.14652</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ssQ3ApH">Echocardiogr Mt Kisco N</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="554" to="560" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tai SB, Lau WR, Gao F, Hamid N, Amanullah MR, Fam JM, et al. E/e&apos; in relation to out- comes in ST-elevation myocardial infarction. Echocardiogr Mt Kisco N 2020;37:554-560.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_CmXJmTW">Doppler-derived haemodynamics performed during admission echocardiography predict in-hospital mortality in cardiac intensive care unit patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Jentzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lanspa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Anavekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Oh</surname></persName>
		</author>
		<idno type="DOI">10.1093/ehjacc/zuac084</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Zk9MmgX">Eur Heart J Acute Cardiovasc Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="640" to="650" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jentzer JC, Tabi M, Wiley BM, Lanspa MJ, Anavekar NS, Oh JK. Doppler-derived haemo- dynamics performed during admission echocardiography predict in-hospital mortality in cardiac intensive care unit patients. Eur Heart J Acute Cardiovasc Care 2022;11:640-650.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_ab26VXW">Mortality prediction in cardiac intensive care unit patients: a systematic review of existing and artificial intelligence augmented approaches</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rafie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Jentzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Noseworthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Kashou</surname></persName>
		</author>
		<idno type="DOI">10.3389/frai.2022.876007</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HAFDEn8">Front Artif Intell</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">876007</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rafie N, Jentzer JC, Noseworthy PA, Kashou AH. Mortality prediction in cardiac inten- sive care unit patients: a systematic review of existing and artificial intelligence augmen- ted approaches. Front Artif Intell 2022;5:876007.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_ChzUsMX">Derivation and validation of a novel cardiac intensive care unit admission risk score for mortality</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Jentzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Anavekar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Murphree</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Keegan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wiley</surname></persName>
		</author>
		<idno type="DOI">10.1161/jaha.119.013675</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ru4SmCF">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">13675</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jentzer JC, Anavekar NS, Bennett C, Murphree DH, Keegan MT, Wiley B, et al. Derivation and validation of a novel cardiac intensive care unit admission risk score for mortality. J Am Heart Assoc 2019;8:e013675.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_22CNp5M">A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models</title>
		<author>
			<persName><forename type="first">E</forename><surname>Christodoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Steyerberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Verbakel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Calster</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2019.02.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AvXaE6D">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="12" to="22" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. A sys- tematic review shows no performance benefit of machine learning over logistic regres- sion for clinical prediction models. J Clin Epidemiol 2019;110:12-22.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_tESYfbQ">Distribution-sensitive unbalanced data oversampling method for medical diagnosis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jia</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10916-018-1154-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_x5PyYa4">J Med Syst</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page">39</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Han W, Huang Z, Li S, Jia Y. Distribution-sensitive unbalanced data oversampling meth- od for medical diagnosis. J Med Syst 2019;43:39.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
